AS
Annabel Samimy Stifel Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
92.3%
Neutral
7.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $50 |
331%
upside
| 2 | +18% |
0
%
| 5 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $17 |
152%
upside
| 1 | -11% |
0
%
| 13 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $18 |
23%
upside
| 1 | -7% |
0
%
| 19 Dec ‘25 5 months ago |
|
|
|
Hold
Maintained
| $55 |
25%
upside
| 1 | – |
–
| 19 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $45 |
536%
upside
| 1 | -34% |
0
%
| 19 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $52 |
117%
upside
| 1 | -30% |
0
%
| 19 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $50 |
28%
upside
| 1 | +5.3% |
0
%
| 19 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $48 |
17%
upside
| 1 | -23% |
0
%
| 19 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $230 |
9%
downside
| 2 | +46% |
0
%
| 10 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $90 |
109%
upside
| 1 | -17% |
0
%
| 9 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $145 |
24%
upside
| 3 | +70% |
0
%
| 24 Nov ‘25 6 months ago |
|